Evidence mapPaperPMID 23899749Full record

ArticleCerebrovascular diseases (Basel, Switzerland)2013

The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping).

P Amarenco, J Bogousslavsky, L R Caplan, G A Donnan, M E Wolf, M G Hennerici

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Cerebrovascular diseases (Basel, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06649240 (Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke), which is not on this map. Cited by 134 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 3 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06649240 narecruitingstarted 2024, after this paper: background citation

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke (SVO70)

Ran2024Enrolled4,016Registered outcomes7Posted comparisons0ConditionsCardiovascular Diseases, Cholesterol, LDL, Ischemic Stroke, Secondary PreventionArmsPCSK9 inhibitor, Statins and/or Ezetimibe
Open the trial in the graph
3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 3 syntheses or guidelines pooled it, 383 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Observational
  10. The role of computed tomography in thrombus characterization: Insights from a stroke cohort of known and unknown etiology.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Tracing Inflammation in Ischemic Stroke: Biomarkers and Clinical Insight.International journal of molecular sciences · 2025
    Review
  16. Clinical insights on "characteristics and impacts of large artery atherosclerosis (LAA) versus cardioembolism (CE) subtypes in large hemispheric infarction (LHI) of the middle cerebral artery (MCA)".Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  17. Comparative analysis of outcome-associated factors following endovascular treatment for intracranial atherosclerotic disease and cardioembolism: A subanalysis of the K-NET registry.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  18. BrainEpilepsia · 2025
    Article
  19. Review
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

P Amarenco
J Bogousslavsky
L R Caplan
G A Donnan
M E Wolf
M G Hennerici
Heidelberg University · DEBeth Israel Deaconess Medical Center · USClinique Valmont · CHInserm · FRThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ASCO phenotyping (A: atherosclerosis; S: small-vessel disease; C: cardiac pathology; O: other causes) assigns a degree of likelihood of causal relationship to every potential disease (1 for potentially causal, 2 for causality is uncertain, 3 for unlikely causal but the disease is present, 0 for absence of disease, and 9 for insufficient workup to rule out the disease) commonly encountered in ischemic stroke describing all underlying diseases in every patient. In this new evolution of ASCO called ASCOD, we have added a 'D' for dissection, recognizing that dissection is a very frequent disease in young stroke patients. We have also simplified the system by leaving out the 'levels of diagnostic evidence', which has been integrated into grades 9 and 0. Moreover, we have also changed the cutoff for significant carotid or intracranial stenosis from 70% to more commonly used 50% luminal stenosis, and added a cardiogenic stroke pattern using neuroimaging. ASCOD captures and weights the overlap between all underlying diseases present in ischemic stroke patients.

Indexed as

Aortic DissectionBrain IschemiaCarotid StenosisCausalityCerebral Small Vessel DiseasesHeart DiseasesHumansIntracranial AneurysmIntracranial ArteriosclerosisIntracranial EmbolismPhenotype

Identifiers

PMID23899749
OpenAlexW2018866069

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.